Annual ROE
-31.31%
+72.11%+69.73%
December 1, 2023
Summary
- As of February 7, 2025, TNFA annual return on equity is -31.31%, with the most recent change of +72.11% (+69.73%) on December 1, 2023.
- During the last 3 years, TNFA annual ROE has fallen by -211.79% (-117.35%).
- TNFA annual ROE is now -117.35% below its all-time high of 180.48%, reached on December 1, 2020.
Performance
TNFA ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-233.94%
-54.87%-30.64%
September 1, 2024
Summary
- As of February 7, 2025, TNFA quarterly return on equity is -233.94%, with the most recent change of -54.87% (-30.64%) on September 1, 2024.
- Over the past year, TNFA quarterly ROE has dropped by -204.11% (-684.24%).
- TNFA quarterly ROE is now -212.32% below its all-time high of 208.28%, reached on December 1, 2020.
Performance
TNFA Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
TNFA ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +69.7% | -684.2% |
| 3 y3 years | -117.3% | -209.4% |
| 5 y5 years | -117.3% | -213.8% |
TNFA ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +75.2% | -684.2% | at low |
| 5 y | 5-year | -117.3% | +75.2% | -212.3% | at low |
| alltime | all time | -117.3% | +75.2% | -212.3% | at low |
TNF Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -233.94%(+30.6%) |
| Jun 2024 | - | -179.07%(+81.7%) |
| Mar 2024 | - | -98.57%(+230.4%) |
| Dec 2023 | -31.31%(-69.7%) | -29.83%(-23.0%) |
| Sep 2023 | - | -38.75%(-57.3%) |
| Jun 2023 | - | -90.83%(+13.9%) |
| Mar 2023 | - | -79.73%(-9.8%) |
| Dec 2022 | -103.42% | -88.40%(+16.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -75.62%(-2.1%) |
| Jun 2022 | - | -77.23%(-37.4%) |
| Mar 2022 | - | -123.39%(+17.7%) |
| Dec 2021 | -126.40%(-170.0%) | -104.84%(-27.6%) |
| Sep 2021 | - | -144.80%(0.0%) |
| Jun 2021 | - | -144.80%(+94.2%) |
| Mar 2021 | - | -74.56%(-135.8%) |
| Dec 2020 | 180.48% | 208.28% |
FAQ
- What is TNF Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for TNF Pharmaceuticals?
- What is TNF Pharmaceuticals annual ROE year-on-year change?
- What is TNF Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for TNF Pharmaceuticals?
- What is TNF Pharmaceuticals quarterly ROE year-on-year change?
What is TNF Pharmaceuticals annual return on equity?
The current annual ROE of TNFA is -31.31%
What is the all time high annual ROE for TNF Pharmaceuticals?
TNF Pharmaceuticals all-time high annual return on equity is 180.48%
What is TNF Pharmaceuticals annual ROE year-on-year change?
Over the past year, TNFA annual return on equity has changed by +72.11% (+69.73%)
What is TNF Pharmaceuticals quarterly return on equity?
The current quarterly ROE of TNFA is -233.94%
What is the all time high quarterly ROE for TNF Pharmaceuticals?
TNF Pharmaceuticals all-time high quarterly return on equity is 208.28%
What is TNF Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, TNFA quarterly return on equity has changed by -204.11% (-684.24%)